What is GoldenExo® NCSK?

NCSK is a native MSC-EV formulation material supplied as a lyophilized presentation with a 5 mL PDRN and HA companion matrix for professional skin research and product development.

How is NCSK different from the engineered SKIN program?

NCSK is a mature native MSC-EV formulation platform. SKIN is a development-stage engineered EV program intended to enhance selected regenerative and microenvironment-regulating signals.

Can the companion formulation be customized?

Alternative HA grades, PDRN levels, buffers, excipients, fill volumes and packaging may be evaluated through a formulation-development project.

Is NCSK a finished consumer cosmetic or injectable product?

No. It is supplied as a professional raw material or development set under the applicable research and further-manufacturing framework.

GoldenExo® NCSK

A formulation-ready lyophilized MSC-EV presentation with a 5 mL companion formulation, designed for professional skin-barrier, repair and rejuvenation research.

Quick Facts

MSC-EV Material for Skin Formulation Development
Particle Content: 2.6E+10 particles / set
Presentation: Lyophilized + 5 mL formulation
Companion Matrix: PDRN + HA
Storage: 2-8°C
Shipping: Ambient or ice-pack
COA
TDS
PDRN + HA
OEM / ODM Support

A native MSC-EV formulation material distinct from the engineered SKIN program.

NCSK is a mature native MSC-EV formulation base for skin-barrier, repair, oxidative-stress and formulation-compatibility research, while engineered SKIN is a development-stage program for selected cargo and pathway enhancement.

Formulation-Ready Set: A lyophilized EV presentation paired with a 5 mL companion matrix for efficient development work.

Native EV Cargo Profile: Supports research into multi-dimensional skin-barrier, oxidative-stress and repair-related signaling.

PDRN and HA Matrix: Provides a familiar formulation basis for professional skin-research and product-prototype programs.

OEM / ODM Flexibility: Concentration, format, excipients, packaging and branded development pathways can be evaluated.

Evaluation pathway designed around product use

01 Source & Cell Bank: Confirm source, cell identity and batch traceability.

02 Culture & Harvest: Control culture system and harvest window by product positioning.

03 Purification & Concentration: Match purification strategy to lyophilized, frozen or formulation-development needs.

04 Fill & Storage: Define specification, packaging and shipping conditions.

05 Quality Evaluation: Combine EV identity, purity, safety and functional tests by project.

06 Application Support: Connect to formulation, delivery, model validation and co-development.

From Skin-Formulation Base to Professional Prototype Development

Source Identity & Traceability: Documented human UC-MSC or defined producer-cell sourcing; Cell-bank identity and batch records; Project-appropriate traceability and source controls

Controlled Manufacturing: Defined culture, harvest and purification workflows; Lyophilized or cryopreserved presentation by product design; Batch consistency and scale-up compatibility

Orthogonal Quality Evaluation: Particle concentration, size and EV identity; Purity, membrane integrity and safety tests; Functional or stability assays selected by project

Batch-Level Documentation: COA, TDS and SDS supplied by project scope; Connection to formulation development and further manufacturing; Support for technical review and collaboration planning

Product-specific analytical focus: Projects may evaluate EV identity, particle recovery, PDRN/HA formulation compatibility, stability, cellular activity and relevant skin-model endpoints.

Where the Product Can Fit

Barrier-Support Research: Study cellular and molecular responses associated with impaired skin-barrier environments.

Repair and Recovery: Evaluate fibroblast, keratinocyte and wound-recovery related research endpoints.

Photoaging Models: Explore oxidative stress, extracellular-matrix and senescence-related pathways.

Formulation Compatibility: Assess mixing, reconstitution, stability and packaging compatibility for professional prototypes.

Key Information for Technical Evaluation

Product Name: GoldenExo® NCSK

Material Type: Native MSC-EV formulation-development material

Particle Content: 2.6E+10 particles / set

Presentation: Lyophilized EV + 5 mL companion formulation

Companion Matrix: PDRN + HA

Storage: 2-8°C

Shipping: Ambient or ice-pack

Application: Skin barrier, repair, photoaging and professional formulation prototypes

The companion formulation may be customized by evaluating HA grade, PDRN level, buffer, excipients, fill volume and packaging.

From Product Supply to Co-Development

Standard Material Supply: Deliver material and agreed documentation according to product specification.

Formulation & Delivery Development: Evaluate concentration, excipients, packaging and application format.

Quality & Stability Research: Extend analytics, stability and model validation by project.

OEM / ODM / CDMO: Connect raw material, prototype and further manufacturing collaboration.

FAQ

What is GoldenExo® NCSK?: NCSK is a native MSC-EV formulation material supplied as a lyophilized presentation with a 5 mL PDRN and HA companion matrix for professional skin research and product development.
How is NCSK different from the engineered SKIN program?: NCSK is a mature native MSC-EV formulation platform. SKIN is a development-stage engineered EV program intended to enhance selected regenerative and microenvironment-regulating signals.
Can the companion formulation be customized?: Alternative HA grades, PDRN levels, buffers, excipients, fill volumes and packaging may be evaluated through a formulation-development project.
Is NCSK a finished consumer cosmetic or injectable product?: No. It is supplied as a professional raw material or development set under the applicable research and further-manufacturing framework.